MedTrace Logo

Frequency Doubling Technology (FDT) Mobile Visual Field Testing

NCT02862158 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2020-10-30

No results posted yet for this study

Summary

This is a single center, prospective study to evaluate the efficacy and reproducibility of frequency doubling technology (FDT)-based visual field devices compared to conventional Humphrey Visual Field (HVF) perimetry. The investigators plan to enroll 500 patients in this study.

Conditions

Interventions

DEVICE

FDT visual field

DEVICE

Standard HVF

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Richard Lee, MD, PhD · University of Miami / Bascom Palmer Eye Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02862158 on ClinicalTrials.gov